Liver disease studies
Studies open for participation
PBC
Elfidence — Treatment for Primary Biliary Cholangitis (PBC)
A phase III randomized, parallel group, double-blind, placebo-controlled, two-arm trial to evaluate the long-term efficacy and safety of Elafibranor 80 mg in adult participants with Primary Biliary Cholangitis (PBC).
Future Studies
MASH Cirrhosis (compensated cirrhosis by MASH)
Enlighten — New Treatment for MASH Cirrhosis (Advanced Liver Disease)
A Phase III Study to Evaluate the Efficacy and Safety of pegozafermine in subjects with compensated cirrhosis as a result of metabolic dysfunction-associated steatohepatitis (MASH).
MASH (early stage with liver fibrosis F2-F3)
BI 1404-0044 — MASH (early stage liver fibrosis) study
A randomized, double-blind, placebo-controlled, multicenter, phase III trial evaluating the long-term efficacy and safety of survodutide weekly injections among adult participants with non-cirrhotic MASH (formerly NASH) and F2-F3 liver fibrosis.
